Private Sector Pharmaceutical Supply and Distribution Channels in Africa : A Focus on Ghana, Malawi and Mali

Show simple item record

collection.link.221
https://openknowledge.worldbank.org/handle/10986/12995
collection.name.221
Health, Nutrition and Population (HNP) Discussion Papers
dc.contributor.author
McCabe, Ariane
dc.contributor.author
Seiter, Andreas
dc.contributor.author
Diack, Aissatou
dc.contributor.author
Herbst, Christopher H.
dc.contributor.author
Dutta, Sheila
dc.contributor.author
Saleh, Karima
dc.date.accessioned
2013-05-28T21:50:29Z
dc.date.available
2013-05-28T21:50:29Z
dc.date.issued
2011-08
dc.date.lastModified
2017-12-13T08:47:49Z
dc.description.abstract
Sustainable access to affordable, high-quality medicines is an important component in all health care systems but remains limited in many African countries. Supply and distribution of medicines are a fundamental aspect of the success of any health system. Disruptions to this supply undermine health outcomes as supply chains have an impact on the availability, cost, and quality of medicines for patients. Common problems associated with the supply and distribution of pharmaceuticals often include poor supply chain management, stock pilfering, insufficient human resources, and limited financing resulting in chronic stock outs. In resource-poor settings where public services fail to meet demand, the private and voluntary sectors are increasingly being called on, prompting some policy makers to consider private mechanisms as alternatives to state-run drug procurement and distribution systems. This study reviews some of the ways in which some countries in Africa organize their private pharmaceutical supply and distribution channels, focusing on three diverse countries: Ghana, Malawi, and Mali. It discusses some of the strengths and challenges associated with such arrangements, as well as relevant options to improve access, availability, quality and affordability of privately supplied pharmaceuticals.
en
dc.identifier
http://documents.worldbank.org/curated/en/2011/08/15476296/private-sector-pharmaceutical-supply-distribution-channels-africa-focus-ghana-malawi-mali
dc.identifier.uri
http://hdl.handle.net/10986/13590
dc.language
English
dc.language.iso
en_US
dc.publisher
World Bank, Washington, DC
dc.relation.ispartofseries
Health, Nutrition and Population (HNP) discussion paper;
dc.rights
CC BY 3.0 IGO
dc.rights.holder
World Bank
dc.rights.uri
http://creativecommons.org/licenses/by/3.0/igo/
dc.subject
ACCESS TO PRODUCTS
dc.subject
ACCOUNTABILITY
dc.subject
ADVERTISING
dc.subject
ANALGESICS
dc.subject
ANTIMALARIALS
dc.subject
ARTISANS
dc.subject
ASPIRIN
dc.subject
BAR CODES
dc.subject
BATCH NUMBERS
dc.subject
BATCHES
dc.subject
BRAND
dc.subject
BRAND NAME
dc.subject
BRAND NAME PRODUCTS
dc.subject
BRAND NAMES
dc.subject
BRANDS
dc.subject
BUSINESS ENVIRONMENT
dc.subject
BUSINESS MODEL
dc.subject
BUSINESS MODELS
dc.subject
BUSINESS PARTNERS
dc.subject
BUSINESSES
dc.subject
BUYER
dc.subject
BUYERS
dc.subject
CAPABILITIES
dc.subject
CARTONS
dc.subject
CERTIFICATION
dc.subject
CHEMISTS
dc.subject
CLINICS
dc.subject
COLD CHAIN
dc.subject
COLLECTION OF DATA
dc.subject
COMMODITIES
dc.subject
COMMODITY
dc.subject
COMMUNICABLE DISEASES
dc.subject
COMMUNITY DEVELOPMENT
dc.subject
COMPETITIVENESS
dc.subject
COMPUTER SYSTEMS
dc.subject
CONSUMER DEMAND
dc.subject
CONSUMER EDUCATION
dc.subject
CONSUMER PRICES
dc.subject
CORRUPTION
dc.subject
DELIVERY SERVICES
dc.subject
DELIVERY SYSTEM
dc.subject
DIABETES
dc.subject
DISCLOSURE
dc.subject
DISTRIBUTION CHANNEL
dc.subject
DISTRIBUTION CHANNELS
dc.subject
DISTRIBUTION NETWORK
dc.subject
DISTRIBUTION OF PHARMACEUTICALS
dc.subject
DISTRIBUTION SYSTEM
dc.subject
DISTRIBUTION SYSTEMS
dc.subject
DOMESTIC MANUFACTURERS
dc.subject
DRUG DONATIONS
dc.subject
DRUG TESTING
dc.subject
DRUGS
dc.subject
ECONOMIC DEVELOPMENT
dc.subject
ELECTRICITY
dc.subject
ELECTRONIC PAYMENT
dc.subject
ELECTRONIC PROCUREMENT
dc.subject
EQUIPMENT
dc.subject
ESSENTIAL DRUGS
dc.subject
EXPENDITURE
dc.subject
EXPENDITURES
dc.subject
FAIR
dc.subject
FINANCIAL INSTITUTIONS
dc.subject
FINANCIAL INVESTMENT
dc.subject
FINANCIAL SERVICE
dc.subject
FINANCIAL SERVICES
dc.subject
FINANCIAL SUPPORT
dc.subject
FINISHED PRODUCTS
dc.subject
FLOW OF GOODS
dc.subject
FLOW OF INFORMATION
dc.subject
FOREIGN CURRENCY
dc.subject
FOREIGN EXCHANGE
dc.subject
GENERIC DRUGS
dc.subject
GENERIC PRODUCTS
dc.subject
GOOD MANUFACTURING PRACTICES
dc.subject
GOVERNMENT CONTRACTS
dc.subject
GOVERNMENT POLICIES
dc.subject
GOVERNMENT POLICY
dc.subject
GOVERNMENT SERVICES
dc.subject
HARMONIZATION
dc.subject
HEALTH CARE
dc.subject
HEALTH CARE WORKERS
dc.subject
HEALTH INSURANCE
dc.subject
HEALTH OUTCOMES
dc.subject
HEALTH SERVICES
dc.subject
HOSPITALIZATION
dc.subject
HOSPITALS
dc.subject
HUMAN RESOURCES
dc.subject
HYPERTENSION
dc.subject
INSPECTION
dc.subject
INSPECTIONS
dc.subject
INTERNATIONAL ACTORS
dc.subject
INTERNATIONAL COMPANIES
dc.subject
INTERNATIONAL ORGANIZATIONS
dc.subject
INVENTORIES
dc.subject
IRRATIONAL USE
dc.subject
LABORATORIES
dc.subject
LAWS
dc.subject
LEGAL SYSTEMS
dc.subject
LICENSE
dc.subject
LICENSES
dc.subject
LIFE EXPECTANCY
dc.subject
LIMITED ACCESS
dc.subject
LOCAL MANUFACTURERS
dc.subject
LOGISTICS COMPANIES
dc.subject
LOGISTICS SYSTEM
dc.subject
MARKET COMPETITION
dc.subject
MARKET FAILURES
dc.subject
MARKET FORCES
dc.subject
MARKET INFORMATION
dc.subject
MARKET RESEARCH
dc.subject
MARKET SHARE
dc.subject
MARKET STUDIES
dc.subject
MARKET VALUE
dc.subject
MARKETING
dc.subject
MATERIAL
dc.subject
MEDICAL STORES
dc.subject
MEDICAL SUPPLIES
dc.subject
MEDICINE
dc.subject
MEDICINES
dc.subject
MIDDLEMEN
dc.subject
MORTALITY
dc.subject
NEW MARKETS
dc.subject
NEW TECHNOLOGIES
dc.subject
NURSES
dc.subject
NUTRITION
dc.subject
PACKAGING
dc.subject
PARASTATALS
dc.subject
PATIENT
dc.subject
PATIENTS
dc.subject
PAYMENT TERMS
dc.subject
PHARMACEUTICAL
dc.subject
PHARMACEUTICAL CONSUMPTION
dc.subject
PHARMACEUTICAL DISPENSING
dc.subject
PHARMACEUTICAL DISTRIBUTION
dc.subject
PHARMACEUTICAL DISTRIBUTION NETWORKS
dc.subject
PHARMACEUTICAL INDUSTRY
dc.subject
PHARMACEUTICAL MANUFACTURERS
dc.subject
PHARMACEUTICAL MANUFACTURING
dc.subject
PHARMACEUTICAL POLICY
dc.subject
PHARMACEUTICAL PRODUCTION
dc.subject
PHARMACEUTICAL PRODUCTS
dc.subject
PHARMACEUTICAL SECTOR
dc.subject
PHARMACEUTICAL SERVICES
dc.subject
PHARMACEUTICAL SUPPLIERS
dc.subject
PHARMACEUTICAL SUPPLIES
dc.subject
PHARMACEUTICAL SUPPLY
dc.subject
PHARMACIES
dc.subject
PHARMACISTS
dc.subject
PHARMACOLOGY
dc.subject
PHARMACY
dc.subject
PHARMACY PRACTICES
dc.subject
PILL
dc.subject
POOLED PROCUREMENT
dc.subject
PRESCRIPTIONS
dc.subject
PRIVATE PHARMACIES
dc.subject
PRIVATE SECTOR
dc.subject
PRIVATE SECTORS
dc.subject
PROCUREMENT
dc.subject
PRODUCT MARKET
dc.subject
PRODUCT PRICING
dc.subject
PRODUCT QUALITY
dc.subject
PUBLIC EDUCATION
dc.subject
PUBLIC HEALTH
dc.subject
PURCHASING
dc.subject
PURCHASING POWER
dc.subject
QUALITY ASSURANCE
dc.subject
QUALITY CONTROL
dc.subject
QUALITY OF SERVICES
dc.subject
QUININE
dc.subject
RADIO
dc.subject
RADIO-FREQUENCY IDENTIFICATION
dc.subject
REGULATORY AUTHORITIES
dc.subject
REGULATORY ENVIRONMENT
dc.subject
REGULATORY FRAMEWORK
dc.subject
REGULATORY FRAMEWORKS
dc.subject
RESULT
dc.subject
RESULTS
dc.subject
RETAIL
dc.subject
RETAIL OUTLETS
dc.subject
RETAIL PHARMACIES
dc.subject
RETAIL PRICES
dc.subject
RETAIL SALES
dc.subject
RETAILING
dc.subject
SALES
dc.subject
SERVICE DELIVERY
dc.subject
SERVICE PROVIDERS
dc.subject
SITES
dc.subject
SPREAD
dc.subject
STOCK MANAGEMENT
dc.subject
STOCKS
dc.subject
STORAGE FACILITIES
dc.subject
STORAGE SPACE
dc.subject
SUBSTITUTION
dc.subject
SUPERVISION
dc.subject
SUPPLIER
dc.subject
SUPPLIERS
dc.subject
SUPPLY CHAIN
dc.subject
SUPPLY CHAIN MANAGEMENT
dc.subject
SUPPLY CHAIN MANAGEMENT SYSTEM
dc.subject
SUPPLY CHAIN OPERATIONS
dc.subject
SUPPLY CHAINS
dc.subject
SUPPLY MANAGEMENT
dc.subject
SUPPLY NETWORKS
dc.subject
SUPPLY OF RAW MATERIALS
dc.subject
TABLETS
dc.subject
TARGETS
dc.subject
TECHNICAL STAFF
dc.subject
THERAPIES
dc.subject
TRADITIONAL MEDICINES
dc.subject
TRANSPORT SYSTEM
dc.subject
TURNOVER
dc.subject
USER
dc.subject
USER FEES
dc.subject
USERS
dc.subject
VACCINES
dc.subject
VALUE CHAIN
dc.subject
VITAMINS
dc.subject
VOLATILITY
dc.subject
WAREHOUSE
dc.subject
WHOLESALE PRICES
dc.subject
WHOLESALER
dc.subject
WHOLESALERS
dc.subject
WHOLESALING
dc.subject
WORKERS
dc.subject
WORKING CAPITAL
dc.title
Private Sector Pharmaceutical Supply and Distribution Channels in Africa : A Focus on Ghana, Malawi and Mali
en
okr.date.disclosure
2011-11-15
okr.doctype
Publications & Research :: Working Paper
okr.doctype
Publications & Research
okr.docurl
http://documents.worldbank.org/curated/en/2011/08/15476296/private-sector-pharmaceutical-supply-distribution-channels-africa-focus-ghana-malawi-mali
okr.globalpractice
Macroeconomics and Fiscal Management
okr.globalpractice
Transport and ICT
okr.globalpractice
Finance and Markets
okr.globalpractice
Trade and Competitiveness
okr.googlescholar.linkpresent
yes
okr.identifier.externaldocumentum
000386194_20111115235716
okr.identifier.internaldocumentum
15476296
okr.identifier.report
65601
okr.language.supported
en
okr.pdfurl
http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2011/11/15/000386194_20111115235716/Rendered/PDF/656010WP00PUBL00PvtSectorPharma0811.pdf
en
okr.region.administrative
Africa
okr.region.country
Ghana
okr.region.country
Malawi
okr.region.country
Mali
okr.topic
International Economics and Trade :: Access to Markets
okr.topic
Private Sector Development :: E-Business
okr.topic
Health Monitoring and Evaluation
okr.topic
Macroeconomics and Economic Growth :: Markets and Market Access
okr.topic
Pharmaceuticals and Pharmacoeconomics
okr.topic
Health
okr.topic
Nutrition and Population
okr.unit
Health, Nutrition & Population (AFTHE)
okr.volume
1 of 1

Show simple item record



This item appears in the following Collection(s)